Medicina
Fachbereich
University of Texas Health Science Center at San Antonio
San Antonio, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von University of Texas Health Science Center at San Antonio (27)
2023
2022
-
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
Journal of Clinical Oncology, Vol. 32
-
Optical coherence tomography in coronary atherosclerosis assessment and intervention
Nature Reviews Cardiology, Vol. 19, Núm. 10, pp. 684-703
-
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Journal for immunotherapy of cancer, Vol. 10, Núm. 2
-
Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52-week results from MATURE, a randomized, placebo-controlled trial
Dermatologic Therapy, Vol. 35, Núm. 3
2021
-
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia
Chest, Vol. 159, Núm. 1, pp. 58-72
-
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM
The Lancet Infectious Diseases, Vol. 21, Núm. 12, pp. e375-e386
2020
-
Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective (BMC Infectious Diseases, (2018), 18, 1, (677), 10.1186/s12879-018-3565-z)
BMC Infectious Diseases
-
Standard anthracycline based versus docetaxel-capecitabine in early high clinical and/or genomic risk breast cancer in the EORTC 10041/BIG 3-04 MINDACT phase III trial
Journal of Clinical Oncology, Vol. 38, Núm. 11, pp. 1186-1197
2019
-
An international perspective on hospitalized patients with viral community-acquired pneumonia
European Journal of Internal Medicine, Vol. 60, pp. 54-70
-
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
Journal of Infection, Vol. 79, Núm. 4, pp. 300-311
-
Prevalence and etiology of community-acquired pneumonia in immunocompromised patients
Clinical Infectious Diseases, Vol. 68, Núm. 9, pp. 1482-1493
2018
-
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients
European Respiratory Journal, Vol. 52, Núm. 2
-
Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study
Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482
-
Microbiological testing of adults hospitalised with community-acquired pneumonia: An international study
ERJ Open Research, Vol. 4, Núm. 4
2016
-
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study
The Lancet Infectious Diseases, Vol. 16, Núm. 12, pp. 1364-1376
-
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis
Journal of Infection, Vol. 72, Núm. 2, pp. 143-151
2011
-
A prospective rAnDomised study of a rotary powered device (OnControl) for Bone marrow aspiration and biopsy
Journal of Clinical Pathology, Vol. 64, Núm. 9, pp. 809-813
-
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis
Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 454-462
2010
-
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians
Annals of the Rheumatic Diseases, Vol. 69, Núm. 4, pp. 700-705